PT2274422T - Vetor de expressão - Google Patents

Vetor de expressão

Info

Publication number
PT2274422T
PT2274422T PT97330740T PT09733074T PT2274422T PT 2274422 T PT2274422 T PT 2274422T PT 97330740 T PT97330740 T PT 97330740T PT 09733074 T PT09733074 T PT 09733074T PT 2274422 T PT2274422 T PT 2274422T
Authority
PT
Portugal
Prior art keywords
expression vector
vector
expression
Prior art date
Application number
PT97330740T
Other languages
English (en)
Portuguese (pt)
Inventor
Shimatani-Shibata Yuko
Shimizu Hitomi
Yonekura Hiromi
Original Assignee
Anaeropharma Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anaeropharma Science Inc filed Critical Anaeropharma Science Inc
Publication of PT2274422T publication Critical patent/PT2274422T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97330740T 2008-04-17 2009-04-16 Vetor de expressão PT2274422T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12452808P 2008-04-17 2008-04-17

Publications (1)

Publication Number Publication Date
PT2274422T true PT2274422T (pt) 2017-06-28

Family

ID=40792658

Family Applications (2)

Application Number Title Priority Date Filing Date
PT97330740T PT2274422T (pt) 2008-04-17 2009-04-16 Vetor de expressão
PT09733604T PT2280717T (pt) 2008-04-17 2009-04-17 Agente terapêutico para doenças anaeróbias

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT09733604T PT2280717T (pt) 2008-04-17 2009-04-17 Agente terapêutico para doenças anaeróbias

Country Status (12)

Country Link
US (3) US8383398B2 (enExample)
EP (2) EP2274422B1 (enExample)
JP (3) JP5735804B2 (enExample)
KR (3) KR101674977B1 (enExample)
CN (2) CN102046791B (enExample)
CA (2) CA2721653C (enExample)
DK (2) DK2274422T3 (enExample)
ES (2) ES2628378T3 (enExample)
HU (2) HUE033561T2 (enExample)
PL (2) PL2274422T3 (enExample)
PT (2) PT2274422T (enExample)
WO (2) WO2009128272A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535939B2 (en) 2010-01-29 2013-09-17 Anaeropharma Science, Inc. Transfection vector
US20130095072A1 (en) * 2010-01-29 2013-04-18 Anaeropharma Science, Inc. Therapeutic agent for ischemic diseases
EP2274422B1 (en) * 2008-04-17 2017-03-15 Anaeropharma Science, Inc. Expression vector
US9730968B2 (en) 2008-04-17 2017-08-15 Anaeropharma Science, Inc. Therapeutic agent for ischemic diseases
US8338162B2 (en) * 2009-04-17 2012-12-25 Anaeropharma Science, Inc. Obligately anaerobic mutant lactic acid bacterium and preparation method therefor, and expression vector functioning in obligately anaerobic lactic acid bacterium
WO2013008881A1 (ja) * 2011-07-13 2013-01-17 株式会社アネロファーマ・サイエンス 虚血性疾患治療薬
KR20170088866A (ko) 2014-12-03 2017-08-02 가부시키가이샤 아네로파마·사이엔스 공발현 플라스미드
KR101892722B1 (ko) * 2015-01-19 2018-08-28 고쿠리츠 다이가쿠 호우징 신슈 다이가쿠 허혈성 질환 치료제
LU100900B1 (de) * 2018-08-10 2020-02-17 Thomas Melchior Homann Verbindungen zur modulation von a-ketoglutarsäure (2kg)-abhängigen oxygenasen
WO2021038975A1 (ja) 2019-08-28 2021-03-04 株式会社アネロファーマ・サイエンス ダイアボディ型ＢｓＡｂを発現・分泌するビフィドバクテリウム属細菌
CN112999215B (zh) * 2019-12-20 2024-06-21 复旦大学 呋喃酮糖苷类化合物的应用
CN115400154A (zh) * 2022-08-10 2022-11-29 深圳未知君生物科技有限公司 长双歧杆菌在制备治疗自闭症谱系障碍的药物中的应用
WO2024187069A1 (en) * 2023-03-08 2024-09-12 University Of Florida Research Foundation, Incorporated Engineering enterobacteria to site-specifically activate the anticancer prodrug 5-fluorocytosine for treating colon cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713601D0 (en) * 1987-06-10 1987-07-15 Unilever Plc Fermentation
WO1991009131A1 (en) * 1989-12-20 1991-06-27 Valio Finnish Cooperative Dairies Association Cloning vector for use in lactic acid bacteria
US6984513B2 (en) 1994-03-03 2006-01-10 The Board Of Trustees Of The Leland Stanford Junior University Anaerobe targeted enzyme-mediated prodrug therapy
US6416754B1 (en) 1994-03-03 2002-07-09 The Board Of Trustees Of The Leland Stanford Junior University Anaerobe targeted enzyme-mediated prodrug therapy
TW357191B (en) * 1996-06-04 1999-05-01 Food Industry Development Res Institute Bifidobacteria strains with acid, bile salt and oxygen tolerance and their culture method the invention relates to bifidobacteria strains with acid, bile salt and oxygen tolerance and their culture method
JP2000060541A (ja) * 1998-08-27 2000-02-29 Fuyuki Mitsuyama ビフィズス菌増殖促進物質と整腸物質とビフィズス菌製剤
JP3642755B2 (ja) 2000-09-21 2005-04-27 純 天野 嫌気性菌を用いた遺伝子治療用医薬
CA2342040C (en) * 2000-09-21 2012-07-10 Kyowa Hakko Kogyo Co., Ltd. Anaerobic bacterium as a drug for cancer gene therapy
US7008633B2 (en) * 2000-12-18 2006-03-07 Board Of Regents, The University Of Texas System Local regional chemotherapy and radiotherapy using in situ hydrogel
KR100457879B1 (ko) * 2001-02-24 2004-11-18 주식회사 비피도 비피도박테리움 유래 신규 플라스미드, 이를 이용한 재조합 발현 벡터 및 형질전환 방법
PT2088193E (pt) 2004-11-24 2011-02-24 Anaeropharma Science Inc Novo vector vaivém
ES2548516T3 (es) * 2005-01-21 2015-10-19 The Research Foundation Of The State University Of New York Métodos para el tratamiento de la capsulitis adhesiva
EP1867714B1 (en) 2005-04-08 2013-09-18 Anaeropharma Science Inc. 5-fluorouracil-resistant bacteria and method for production thereof
CA2646244A1 (en) * 2006-03-27 2007-10-04 Government Of The United States Of Americas, As Represented By The Secre Tetracycline compounds and methods of treatment
GB2439310A (en) * 2006-04-13 2007-12-27 Ambrozea Inc Fermentation residuals from genetically-modified microorganisms
JP5048661B2 (ja) 2006-05-24 2012-10-17 株式会社アネロファーマ・サイエンス 遺伝子輸送担体作製方法
EP2274422B1 (en) * 2008-04-17 2017-03-15 Anaeropharma Science, Inc. Expression vector

Also Published As

Publication number Publication date
CN102046190A (zh) 2011-05-04
EP2274422B1 (en) 2017-03-15
US20110110893A1 (en) 2011-05-12
KR20160102584A (ko) 2016-08-30
JP5514735B2 (ja) 2014-06-04
JP2011518112A (ja) 2011-06-23
EP2280717A1 (en) 2011-02-09
PT2280717T (pt) 2018-10-04
WO2009128275A9 (en) 2010-11-11
CA2721664A1 (en) 2009-10-22
CN102046791B (zh) 2013-09-18
CA2721653A1 (en) 2009-10-22
EP2274422A1 (en) 2011-01-19
CN102046791A (zh) 2011-05-04
JP6089025B2 (ja) 2017-03-01
US8470311B2 (en) 2013-06-25
ES2686080T3 (es) 2018-10-16
CA2721653C (en) 2018-03-20
CA2721664C (en) 2018-01-23
CN102046190B (zh) 2013-03-13
US20090264513A1 (en) 2009-10-22
WO2009128275A4 (en) 2010-02-18
JP2015091243A (ja) 2015-05-14
KR101674977B1 (ko) 2016-11-10
US20130122582A1 (en) 2013-05-16
DK2274422T3 (en) 2017-07-03
PL2280717T3 (pl) 2018-10-31
WO2009128272A1 (en) 2009-10-22
WO2009128275A1 (en) 2009-10-22
DK2280717T3 (en) 2018-09-10
KR20100134765A (ko) 2010-12-23
JP2011517929A (ja) 2011-06-23
PL2274422T3 (pl) 2017-09-29
EP2280717B1 (en) 2018-05-30
HUE039768T2 (hu) 2019-02-28
KR101671283B1 (ko) 2016-11-02
WO2009128272A4 (en) 2010-02-18
KR20110021784A (ko) 2011-03-04
US8383398B2 (en) 2013-02-26
WO2009128272A9 (en) 2010-11-11
HUE033561T2 (hu) 2017-12-28
JP5735804B2 (ja) 2015-06-17
ES2628378T3 (es) 2017-08-02

Similar Documents

Publication Publication Date Title
PL2918172T3 (pl) Połączenia środków kontroli biologicznej i fungicydów
PT2274422T (pt) Vetor de expressão
GB0810912D0 (en) Vector
GB0820631D0 (en) Vectors
EP2285758A4 (en) DISPOSABLE PACKAGING FOR FERTILIZER-PESTICIDE
EP2313147A4 (en) crimping
PL2367943T3 (pl) Ssaczy wektor ekspresyjny
GB0807353D0 (en) Suit-match
GB0808287D0 (en) Metasox
GB0810154D0 (en) Expression vector
GB0800389D0 (en) Gileo hang-it
GB0805771D0 (en) Teledeck
GB0810659D0 (en) Permenforce
GB0803221D0 (en) Wrist-pull
GB0823425D0 (en) Vectors
GB0709375D0 (en) Vector
GB2462330B (en) Suit
GB0804837D0 (en) Concept three
GB0807122D0 (en) UVShrinkbuster
GB0815385D0 (en) Gymclip
GB0800531D0 (en) Webcanvas
GB0801371D0 (en) Hipsert
GB0804761D0 (en) Stuey duey
GB0805241D0 (en) Zuit-zuit
GB0803147D0 (en) Subtider